课题基金 / 基金详情

Stimulator of Interferon Genes Pathway Activation as an Immunotherapeutic Strategy for Soft Tissue Sarcoma

Stimulator of Interferon Genes Pathway Activation as an Immunotherapeutic Strategy for Soft Tissue Sarcoma
干扰素基因通路激活刺激剂作为软组织肉瘤的免疫治疗策略
批准号：
406594
负责人：
Marritt Kayla L
金额：
$1.27万
依托单位：
University of Calgary
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-12-01 至 2019-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406594&lang=en
关键词：
5 6-Dimethylxanthenone-4-Acetic Acid (Dmxaa) Animal Model Bone Immunotherapy Intra-Tumoural Metastasis Sarcoma Stimulator Of Interferon Genes (Sting) T-Cells Undifferentiated Pleomorphic Sarcoma (Ups)

项目摘要

项目成果

相关文献

中文摘要
翻译
肉瘤是源自骨骼、肌肉、脂肪和其他结缔组织的侵袭性癌症。肉瘤相对罕见；因此，研究还远远不够。传统的治疗方法包括放疗、手术和化疗，而且严格、有毒、可能
英文摘要
Sarcomas are aggressive cancers derived from bone, muscle, fat, and other connective tissue. Sarcomas are relatively rare; thus, grossly understudied. Conventional treatment consists of radiation, surgery, and chemotherapy, and is rigorous, toxic, and may
期刊论文(0)
专著(0)
科研奖励(0)
会议论文